Margaret M. Manson

Margaret M. Manson

Auto-generated profile, based on publicly available information

Margaret M. Manson

Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester, Leicestershire, United Kingdom

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2001
Verified
Journal Article
Closed access
RSR A Sharma
R A Sharma
HMH R McLelland
H R McLelland
KHK A Hill
K A Hill
CIC R Ireson
C R Ireson
SES A Euden
S A Euden
WSW P Steward
W P Steward

1 August 2004 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
MAMark J. Anderton
Mark J. Anderton
MMMargaret M. Manson
Margaret M. Manson
RVRichard D. Verschoyle
Richard D. Verschoyle
AGAndreas Gescher
Andreas Gescher
JLJohn H. Lamb
John H. Lamb
MWMarion L. Williams
Marion L. Williams
Indole-3-carbinol (I3C) and 3,3′-diindolylmethane (DIM) are promising cancer chemopreventive agents in rodent models, but there is a paucity of data on their pharmacokinetics and tissue disposition. The disposition of I3C and its acid condensation products, DIM, [2-(indol-3-ylmethyl)-indol-3-yl]indol-3-ylmethane (LTr1), indolo[3,2b]carbazole (ICZ) and 1-(3-hydroxymethyl)-indolyl-3-indolylmethane (HI-IM) was studied, after oral administration of I3C (250 mg/kg) to female CD-1 mice. Blood, liver, kidney, lung, heart, and brain were collected between 0.25 and 24 h after administration and the plasma and tissue concentrations of I3C and its derivatives determined by high-performance liquid chromotography. I3C was rapidly absorbed, distributed, and eliminated from plasma and tissues, falling below the limit of detection by 1 h. Highest concentrations of I3C were detected in the liver where levels were approximately 6-fold higher than those in the plasma. Levels of DIM, LTr1, and HI-IM were much lower, although they persisted in plasma and tissues for considerably longer. DIM and HI-IM were still present in the liver 24 h after I3C administration. Tissue levels of DIM and LTr1 were found to be in equilibrium with plasma at almost every time point measured. In addition to acid condensation products of I3C, a major oxidative metabolite (indole-3-carboxylic acid) and a minor oxidative metabolite (indole-3-carboxaldehyde) were detected in plasma of mice after oral administration of I3C. ICZ was also tentatively identified in the liver of these mice. This study shows for the first time that, after oral administration to mice, I3C, in addition to its acid condensation products, is absorbed from the gut and distributed systemically into a number of well-perfused tissues, thus allowing the possibility for some pharmacological activity of the parent compound in vivo.

1 January 2003 in Trends in Molecular Medicine
Verified
Journal Article
Closed access
MMMargaret M Manson
Margaret M Manson

1 September 2007 in Acta Pharmacologica Sinica
Verified
Journal Article
Open access
LHLynne Howells
Lynne Howells
EMElena P Moiseeva
Elena P Moiseeva
CNChristopher P Neal
Christopher P Neal
BFBethany E Foreman
Bethany E Foreman
CACatherine K Andreadi
Catherine K Andreadi
MMMargaret M Manson
Margaret M Manson
APS (Acta Pharmacologica Sinica), the top pharmacology research journal based in China, publishes original articles and reviews on all aspects of pharmacology and the related life sciences

1 March 2000 in Toxicology Letters
Verified
Journal Article
Closed access
MMMargaret M Manson
Margaret M Manson
AGAndreas Gescher
Andreas Gescher
EHE.ANn Hudson
E.ANn Hudson
SPSimon M Plummer
Simon M Plummer
MSMatthew S Squires
Matthew S Squires
SPSally A Prigent
Sally A Prigent

4 December 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CMChristopher D. Mann
Christopher D. Mann
CBChristopher Bastianpillai
Christopher Bastianpillai
CNChristopher P. Neal
Christopher P. Neal
MMMuhammad M. Masood
Muhammad M. Masood
DJDonald J. L. Jones
Donald J. L. Jones
MMMargaret M. Manson
Margaret M. Manson
In order to achieve a better outcome for pancreatic cancer patients, reliable biomarkers are required which allow for improved diagnosis. These may emanate from a more detailed molecular understanding of the aggressive nature of this disease. Having previously reported that Notch3 activation appeared to be associated with more aggressive disease, we have now examined components of this pathway (Notch1, Notch3, Notch4, HES-1, HEY-1) in more detail in resectable (n = 42) and non-resectable (n = 50) tumours compared to uninvolved pancreas. All three Notch family members were significantly elevated in tumour tissue, compared to uninvolved pancreas, with expression maintained within matched lymph node metastases. Furthermore, significantly higher nuclear expression of Notch1, -3 and -4, HES-1, and HEY-1 (all p≤0.001) was noted in locally advanced and metastatic tumours compared to resectable cancers. In survival analyses, nuclear Notch3 and HEY-1 expression were significantly associated with reduced overall and disease-free survival following tumour resection with curative intent, with nuclear HEY-1 maintaining independent prognostic significance for both outcomes on multivariate analysis. These data further support a central role for Notch signalling in pancreatic cancer and suggest that nuclear expression of Notch3 and its target gene, HEY-1, merit validation in biomarker panels for diagnosis, prognosis and treatment efficacy. A peptide fragment of Notch3 was detected in plasma from patients with inoperable pancreatic cancer, but due to wide inter-individual variation, mean levels were not significantly different compared to age-matched controls.